A deeper understanding of the mechanisms by which estrogen-dependent cancers act through specific signaling pathways of different estrogen receptors is helping to develop drugs that target these pathways, potentially leading to more effective treatments for estrogen-dependent cancers and greater benefits for women’s health. The gene discussed is ESR1; the disease is cancer.